Streetbeat News

Stock Prices

QRVO

Qorvo (NASDAQ:QRVO) reported Q1 2025 adjusted EPS of $0.87, beating the estimate of $0.71. However, sales of $886.7 million missed the estimate of $851.882 million. This represents a significant decrease from $651.164 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:01 pm

SWKS

Skyworks Solutions (NASDAQ:SWKS) reported Q3 earnings of $1.21 per share, missing the $1.23 estimate, and sales of $905.50M, beating the $900.40M estimate. Earnings decreased by 30.06% YoY, and sales decreased by 15.47% YoY.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:01 pm

PCRX

Pacira BioSciences (NASDAQ:PCRX) reported Q2 2024 earnings of $0.89 per share, beating the analyst estimate of $0.69 by 28.99%. Sales were $178.023 million, surpassing the $172.497 million estimate. Both earnings and sales showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:01 pm

FGEN

Trading for FibroGen Inc. (FGEN) was halted at 4:00:59 p.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:01 pm

RIVN

Financial giants have shown a mixed sentiment towards Rivian Automotive (NASDAQ:RIVN) through recent options trades. Analysis reveals 50% bullish and 50% bearish tendencies, with significant trades in both puts and calls. The stock is currently trading at $16.25, with an average analyst price target of $19.0. Upcoming earnings announcement in 7 days.

Portfolio Pulse from Benzinga Insights

July 30, 2024 | 8:00 pm

META

Meta has decided to discontinue its celebrity AI chatbots after they failed to gain traction with users. This move reflects the company's ongoing adjustments in its AI strategy.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 8:00 pm

QCOM

Qualcomm is set to report its Q3 earnings on July 31, with key focus areas being AI, automotive, and smartphone revenue. Analysts expect revenue of $9.22 billion and EPS of $2.25. The company has a strong track record of beating estimates. Despite a recent 14% share price drop, analysts see this as a good entry point, with several raising their price targets.

Portfolio Pulse from Chris Katje

July 30, 2024 | 7:56 pm

NOC

Northrop Grumman's GEM 63 solid rocket boosters successfully launched the USSF-51 mission aboard an Atlas V rocket, providing significant thrust and additional components for the launch vehicle.

Portfolio Pulse from Benzinga Newsdesk

July 30, 2024 | 7:50 pm

ENTG

Recent options trading activity for Entegris (NASDAQ:ENTG) shows a mixed sentiment with a slight bullish tilt. Whales have been targeting a price range of $110 to $145. The stock is currently down 4.37% at $122.2, with RSI indicators suggesting it may be oversold. Next earnings are expected in 1 day.

Portfolio Pulse from Benzinga Insights

July 30, 2024 | 7:46 pm

RMD

Financial giants have shown a bearish sentiment towards ResMed (NYSE:RMD) through unusual options trades. Analysis reveals a mix of bullish and bearish trades, with a significant focus on a price range of $170.0 to $230.0. ResMed's stock is currently trading at $208.09, with an upcoming earnings announcement in 2 days. RBC Capital maintains a Sector Perform rating with a target price of $204.0.

Portfolio Pulse from Benzinga Insights

July 30, 2024 | 7:45 pm